Why aging science is turning to clams, bats and a very different rat
Hi there,
Starting a new week with the latest longevity updates.
Why aging science is turning to clams, bats and a very different rat
Why the next breakthroughs in healthy aging may come from the animal kingdom’s overlooked outliers, and from a rat with a genetic twist.
Americans score 60 out of 100 on longevity prep
John Hancock and MIT AgeLab’s second index finds no change since 2025, with care the weakest area and community the strongest.
Can a gut procedure stop weight regain after GLP-1s?
Fractyl’s Revita hit its six-month goal in a sham-controlled pivotal trial, and the FDA filing is planned for late Q4 2026.
Novo to show real-world Wegovy vs resmetirom data
Twelve abstracts head to The Liver Meeting, including a real-world comparison with resmetirom and four on investigational efruxifermin.
Repeat offender: Huntington’s and the DNA repair clock
Latus Bio's Nature Communications paper models how lowering MSH3 could slow somatic instability – and buy years, perhaps decades.
We are turning the entire longevity landscape into a living, queryable dataset.
Explore DLT here.
You're all caught up. See you again tomorrow.